rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2004-10-7
|
pubmed:abstractText |
Sulfamethoxazole hydroxylamine formation, in combination with long-term oxidative stress, is thought to be the cause of high rates of adverse drug reactions to sulfamethoxazole in human immunodeficiency virus (HIV)-infected subjects. Therefore the goal of this study was to determine the effect of fluconazole, clarithromycin, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with HIV-1 infection.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0009-9236
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
76
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
313-22
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15470330-Adult,
pubmed-meshheading:15470330-Anti-Infective Agents,
pubmed-meshheading:15470330-Area Under Curve,
pubmed-meshheading:15470330-CD4 Lymphocyte Count,
pubmed-meshheading:15470330-Clarithromycin,
pubmed-meshheading:15470330-Drug Interactions,
pubmed-meshheading:15470330-Female,
pubmed-meshheading:15470330-Fluconazole,
pubmed-meshheading:15470330-HIV Infections,
pubmed-meshheading:15470330-HIV-1,
pubmed-meshheading:15470330-Humans,
pubmed-meshheading:15470330-Male,
pubmed-meshheading:15470330-Middle Aged,
pubmed-meshheading:15470330-Rifabutin,
pubmed-meshheading:15470330-Sulfamethoxazole,
pubmed-meshheading:15470330-Trimethoprim-Sulfamethoxazole Combination
|
pubmed:year |
2004
|
pubmed:articleTitle |
The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
|
pubmed:affiliation |
University of Washington, Seattle 98195, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|